Liabilities / Assets
46th percentile
Higher debt load relative to assets than 46% of similar nonprofits.
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
0.02x
Liabilities / Revenue
36th percentile
Higher debt load relative to revenue than 36% of similar nonprofits.
Net Margin
80th percentile
Higher net margin than 80% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
92nd percentile
Faster asset growth than 92% of similar nonprofits.
Revenue Growth
19th percentile
Faster revenue growth than 19% of similar nonprofits.
Balance Sheet
Assets
Up$339,397
Up $153,038 (+82%) from 2018
Net Assets
Up$332,366
Up $247,917 (+294%) from 2018
Liabilities
Down$7,031
Down $94,879 (-93%) from 2018
Revenue And Expenses
Revenue
Down$994,136
Down $171,336 (-15%) from 2018
Expenses
Down$746,219
Down $512,496 (-41%) from 2018
Net Income
Up$247,917
Up $341,160 (+366%) from 2018
Historical Trend
Filing Detail Status
This 2019 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Jump To
Filing Snapshot
- Filing Period
- Jul 1, 2018 to Jun 30, 2019
Mission and Program Overview
Mission
The organization is a partnership of world leaders in als research and care focused on expediting breakthrough treatments and ultimately a cure for als while providing resources and equipment to those living with the disease now. The team of als researchers, doctors, and care practitioners is uniquefor its leadership in efficiency, dedication to innovative research, and commitment to increasing access to care and treatment.
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2019 • Form 990Summary only. Only limited summary data is available for this year.
- Assets
- $339,397
- Liabilities
- $7,031
- Net assets
- $332,366
- Revenue
- $994,136
- Expenses
- $746,219
- Net income
- $247,917